Spots Global Cancer Trial Database for bladder neoplasm
Every month we try and update this database with for bladder neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Comparison of Interfascial Injection Versus Subpectineal Injection on Ultrasound-guided Obturator Nerve Block | NCT05540847 | Bladder Neoplas... | Interfascial In... Subpectineal In... | 18 Years - | Diskapi Teaching and Research Hospital | |
| Can VI-RADS/ADC Accurately Stage Bladder Cancer?? | NCT04167631 | MRI Contrast Me... Bladder Cancer Bladder Disease Bladder Neoplas... Bladder Urothel... Bladder Cancer ... Diagnoses Disea... | Multi-parametri... | 18 Years - | Mansoura University | |
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. | NCT03335059 | Bladder Cancer Bladder Neoplas... Bladder Tumors Cancer of Bladd... Cancer of the B... Malignant Tumor... Neoplasms, Blad... Urinary Bladder... Carcinoma in Si... Papillary Carci... BCG-Unresponsiv... | Synergo® RITE +... | 18 Years - | Medical Enterprises Ltd. | |
| Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer | NCT01200992 | Bladder Neoplas... Neoplasm Recurr... Transitional Ce... Carcinoma in Si... Mycobacterium | EN3348 Mitomycin C | 18 Years - | Bioniche Life Sciences Inc. | |
| Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT | NCT04839029 | Bladder Cancer Bladder Neoplas... | Bipolar En bloc... Monopolar En bl... | 18 Years - | Benha University | |
| A Study of MLN8054 in Patients With Advanced Solid Tumors | NCT00249301 | Breast Neoplasm Colon Neoplasm Pancreatic Neop... Bladder Neoplas... | MLN8054 | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | NCT00722553 | Carcinoma, Tran... Bladder Cancer Bladder Neoplas... | Pralatrexate In... Vitamin B12 Folic Acid | 18 Years - | Acrotech Biopharma Inc. | |
| A Study of MLN8054 in Patients With Advanced Solid Tumors | NCT00249301 | Breast Neoplasm Colon Neoplasm Pancreatic Neop... Bladder Neoplas... | MLN8054 | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation | NCT03591367 | Bladder Cancer Bladder Disease Bladder Neoplas... Micro-RNA | MicroRNAs-155 Human telomeras... | 18 Years - | Mansoura University | |
| A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors | NCT03914794 | Bladder Cancer NMIBC Non-Muscle Inva... Urothelial Carc... | Pemigatinib | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Smurf2 Gene Expression in Urinary Tract Tumors | NCT05134623 | Bladder Neoplas... | immunohistochem... | 18 Years - | Ziv Hospital | |
| Pre-Operative Single Shot Rectus Sheath Block | NCT03458598 | Bladder Neoplas... Prostate Neopla... Pelvic Neoplasm Urologic Neopla... Opioid Use Anesthesia, Loc... Pain, Postopera... | Rectus sheath b... Bilateral rectu... Patient control... Subcutaneous in... | 18 Years - | University of Alberta | |
| Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. | NCT06167356 | Non Muscle Inva... Non-Muscle Inva... Non-Muscle Inva... Bladder Cancer Bladder Disease Bladder Neoplas... Bladder Urothel... Bladder Cancer ... Bladder Cancer ... Bladder Urothel... Bladder Urothel... | 18 Years - | IRCCS San Raffaele | ||
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | NCT04075305 | Oncology Breast Cancer Prostate Cancer Gynecologic Can... Brain Tumor Brain Cancer Gynecologic Tum... Prostate Tumor Prostate Neopla... Breast Tumor Radiation Toxic... Quality of Life Rectal Cancer Rectal Tumor Rectal Neoplasm... Lung Cancer Lung Tumor Lung Neoplasm Esophageal Canc... Esophagus Cance... Esophageal Tumo... Esophageal Neop... Esophagus Tumor Esophagus Neopl... Pancreatic Canc... Pancreatic Tumo... Pancreatic Neop... Head and Neck C... Head and Neck N... Head and Neck T... Tumor Neoplasms Bladder Cancer Bladder Neoplas... Liver Cancer Liver Neoplasms Liver Metastase... Oligometastases | Radiation thera... | 18 Years - | UMC Utrecht | |
| En Bloc TURBT With Collins Loop vs Conventional TURBT | NCT05027412 | Bladder Cancer Bladder Neoplas... Bladder Urothel... Bladder Cancer ... Urothelial Carc... | En bloc TURBT C... Conventional TU... | 18 Years - | Hospital Universitario de Fuenlabrada | |
| Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer | NCT01200992 | Bladder Neoplas... Neoplasm Recurr... Transitional Ce... Carcinoma in Si... Mycobacterium | EN3348 Mitomycin C | 18 Years - | Bioniche Life Sciences Inc. | |
| Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block | NCT05022160 | Bladder Neoplas... Prostatic Neopl... | pudendal nerve ... | 18 Years - 60 Years | Armed Forces Hospital, Pakistan | |
| Transurethral Modified En Bloc Resection For Large Bladder Tumours. | NCT04081246 | Bladder Cancer Bladder Neoplas... Bladder Tumor | Bipolar transur... | 18 Years - 80 Years | Chinese University of Hong Kong | |
| Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT | NCT04839029 | Bladder Cancer Bladder Neoplas... | Bipolar En bloc... Monopolar En bl... | 18 Years - | Benha University | |
| Confocal Laser Endomicroscopy in the Lower Urinary Tract | NCT03013894 | Bladder Neoplas... Urothelial Carc... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| Personalized Urine Biomarker for Patients With Bladder Cancer | NCT05467267 | Bladder Neoplas... | TURBT | 18 Years - | Ziv Hospital | |
| Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | NCT00722553 | Carcinoma, Tran... Bladder Cancer Bladder Neoplas... | Pralatrexate In... Vitamin B12 Folic Acid | 18 Years - | Acrotech Biopharma Inc. | |
| The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation | NCT03591367 | Bladder Cancer Bladder Disease Bladder Neoplas... Micro-RNA | MicroRNAs-155 Human telomeras... | 18 Years - | Mansoura University | |
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. | NCT03335059 | Bladder Cancer Bladder Neoplas... Bladder Tumors Cancer of Bladd... Cancer of the B... Malignant Tumor... Neoplasms, Blad... Urinary Bladder... Carcinoma in Si... Papillary Carci... BCG-Unresponsiv... | Synergo® RITE +... | 18 Years - | Medical Enterprises Ltd. | |
| Personalized Urine Biomarker for Patients With Bladder Cancer | NCT05467267 | Bladder Neoplas... | TURBT | 18 Years - | Ziv Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
